GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Astrazeneca Plc (AZN) [hlAlert]

Rating:
Overweight
AZN
up 11.00 %

Astrazeneca Plc (AZN) upgraded to Overweight by HSBC Securities

Posted on: Wednesday,  Mar 19, 2008  8:25 AM ET by HSBC Securities

HSBC Securities rated Overweight Astrazeneca Plc (NYSE: AZN) on 03/19/2008, when the stock price was $18.17. Since then, Astrazeneca Plc
has gained 11.01% of its value until HSBC Securities rated AZN Neutral on 04/02/2008, when the price was $20.17.
If you would have followed this HSBC Securities's recommendation on AZN, you would have gained 11% of your investment in 14 days.

AstraZeneca PLC (AstraZeneca) is engaged in the discovery, development, manufacturing and marketing of prescription pharmaceuticals and biological products for important areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. The Company?s product portfolio comprise: Arimidex, Crestor, Nexium, Seroquel and Symbicort. It has operations in various markets, such as China, United Kingdom, Sweden and the United States. It has 26 manufacturing sites in 18 countries. Cardiovascular product pipeline includes Saxagliptin, Dapagliflozin, Atherosclerosis/dyslipidaemia, Thrombosis and Atrial fibrillation. Gastrointestinal pipeline includes life cycle management initiatives. AstraZeneca?s Infection pipeline MedImmune and Dedicated tuberculosis (TB) research. Oncology product pipeline includes Zactima (vandetanib), Zactima (vandetanib), ZD4054 and MedImmune.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/26/2008 8:25 AM Sell
None
21.66
as of 12/24/2008
1 Week up  0.54 %
1 Month down  -4.77 %
3 Months up  12.06 %
1 YTD up  35.07 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/2/2008 8:25 AM Hold
None
20.17
3/19/2008 8:25 AM Buy
None
18.17
2/1/2008 8:25 AM Hold
None
20.63

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy